148 related articles for article (PubMed ID: 33806743)
1. Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation.
Noble J; Metzger A; Naciri Bennani H; Daligault M; Masson D; Terrec F; Imerzoukene F; Bardy B; Fiard G; Marlu R; Chevallier E; Janbon B; Malvezzi P; Rostaing L; Jouve T
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33806743
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
[TBL] [Abstract][Full Text] [Related]
3. Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units.
Paglialonga F; Schmitt CP; Shroff R; Vondrak K; Aufricht C; Watson AR; Ariceta G; Fischbach M; Klaus G; Holtta T; Bakkaloglu SA; Zurowska A; Jankauskiene A; Vande Walle J; Schaefer B; Wright E; Connell R; Edefonti A
Pediatr Nephrol; 2015 Jan; 30(1):103-11. PubMed ID: 25135618
[TBL] [Abstract][Full Text] [Related]
4. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of plasmapheresis and semi-selective immunoadsorption for removal of anti-HLA antibodies.
Jambon F; Merville P; Guidicelli G; Taton B; De Précigout V; Couzi L; Moreau K; Visentin J
J Clin Apher; 2021 Jun; 36(3):291-298. PubMed ID: 33253430
[TBL] [Abstract][Full Text] [Related]
6. Excellent outcome after desensitization in high immunologic risk kidney transplantation.
Lim JH; Cho JH; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Yoo ES; Won DI; Kim CD
PLoS One; 2019; 14(9):e0222537. PubMed ID: 31550258
[TBL] [Abstract][Full Text] [Related]
7. Non-tolerability of double-filtration plasmapheresis in antibody-incompatible kidney transplant candidates.
Hebibi H; Weclawiak H; Rostaing L; Beaudreuil S; Allal A; François H; Durrbach A; Kamar N
Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):297-301. PubMed ID: 25758878
[TBL] [Abstract][Full Text] [Related]
8. Double filtration plasmapheresis for children with different types of critical kidney diseases: a single-center retrospective cohort study.
Zhang Y; Xie Q; Chen Y; Yang J; Huang S; Deng L; Zhou J
Transl Pediatr; 2023 Mar; 12(3):354-363. PubMed ID: 37035407
[TBL] [Abstract][Full Text] [Related]
9. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
[TBL] [Abstract][Full Text] [Related]
10. Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA Antibodies.
Maillard N; Absi L; Claisse G; Masson I; Alamartine E; Mariat C
Blood Purif; 2015; 40(2):167-72. PubMed ID: 26278703
[TBL] [Abstract][Full Text] [Related]
11. Kidney transplantation in highly sensitized recipients.
Park Y; Ko EJ; Chung BH; Yang CW
Kidney Res Clin Pract; 2021 Sep; 40(3):355-370. PubMed ID: 34233438
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates.
Rostaing L; Congy N; Aarnink A; Maggioni S; Allal A; Sallusto F; Game X; Kamar N
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():201-6. PubMed ID: 25894155
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Combined Desensitization Therapy Based on Protein A Immunoadsorption on Anti-human Leukocyte Antigen Antibodies in Sensitized Kidney Transplant Recipients: A Retrospective Study.
Chen X; Wang Y; Dong P; Wang J; Yu X; Yu B
Cureus; 2022 Sep; 14(9):e28661. PubMed ID: 36196288
[TBL] [Abstract][Full Text] [Related]
14. Double filtration plasmapheresis combined with rituximab for donor-specific antibody desensitization in haploidentical haematopoietic stem cell transplantation.
Liu L; Ji X; Zhu P; Yang L; Shi J; Zhao Y; Lai X; Yu J; Fu H; Ye Y; Wu Y; Ying J; Huang H; Luo Y
Br J Haematol; 2023 Dec; 203(5):829-839. PubMed ID: 37621146
[TBL] [Abstract][Full Text] [Related]
15. [Indications for apheresis in kidney transplant recipients: apheresis in the hyperimmune patient].
Busnach G; Di Leo L
G Ital Nefrol; 2012; 29 Suppl 54():S22-6. PubMed ID: 22388825
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
[TBL] [Abstract][Full Text] [Related]
17. Acceptable Donor-Specific Antibody Levels Before and After Desensitization Therapy in Living Donor Kidney Transplantation.
In JW; Nam M; Rho EY; Shin S; Hong YJ; Park KU; Song EY
Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013363
[TBL] [Abstract][Full Text] [Related]
18. Tandem hemodialysis and DFPP: Procedure, safety and cost-effectiveness in patients requiring chronic hemodialysis and lipid apheresis.
Moranne O; Chauvel F; Pambrun E; Ahmadpoor P; Prelipcean C; Wuillai A; Chkair S; Messikh Z
J Clin Apher; 2022 Oct; 37(5):476-488. PubMed ID: 36195967
[TBL] [Abstract][Full Text] [Related]
19. One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia.
Jalalonmuhali M; Ng KP; Mohd Shariff NH; Lee YW; Wong AH; Gan CC; Lim SK
Transplant Proc; 2020; 52(6):1718-1722. PubMed ID: 32448671
[TBL] [Abstract][Full Text] [Related]
20. Kidney transplantation from HLA-incompatible live donors: Efficiency and outcome of 32 patients after desensitisation.
Fernández C; Calvo M; Leite N; López A; Ferreiro T; Ribera R; Seijo R; Alonso Á
Nefrologia; 2017; 37(6):638-645. PubMed ID: 28734583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
